Collectively, these findings provide mechanistic insights into structure–activity relationships and highlight sesquiterpene lactone scaffolds as promising candidates for the development of targeted JAK2 inhibitors in cervical cancer therapy. Here, JAK2 is linked to cervical carcinoma.